Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Cash and Cash Equivalents [Axis]
Letter of Credit [Member]
JP Morgan Chase [Member]
Cash In US Bank [Member]
Cash Equivalents In US Treasury Bills [Member]
Cash In Australian Bank [Member]
Transaction Type [Axis]
Stock Based Compensation [Member]
Class of Stock [Axis]
Prefunded Warrants [Member]
Common Warrants [Member]
Inducement Warrants [Member]
Placement Agent Warrants [Member]
Securities Purchase Agreement [Member]
Counterparty Name [Axis]
Director 4 [Member]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
May 2024 Public Offering [Member]
Class A Warrants [Member]
Class B Warrants [Member]
Placement Agent [Member]
Director 1 [Member]
Director 2 [Member]
Director 3 [Member]
September 2025 Public Offering [Member]
December 2025 Warrant Inducment [Member]
Options Held [Member]
Warrant [Member]
Exercise Price Range [Axis]
$9.00 or Below [Member]
$46.4 or Below [Member]
Equity Option [Member]
Exercise Price $102.40-112.8 [Member]
Exercise Price $201.6 [Member]
Non Employee Directors [Member]
Related Party Transaction [Axis]
Accrued Vacation Balances [Member]
Separation Agreement [Member]
Accrued Board Fees [Member]
Accrued Vacation To All Employees [Member]
Accrued Separation Expenses [Member]
Income Tax Jurisdiction [Axis]
Income Tax Jurisdiction, Domestic Federal [Member]
Income Tax Jurisdiction, Domestic State and Local [Member]
Income Tax Jurisdiction, Foreign [Member]
Long-Lived Asset, Class [Axis]
Manufacturing Space [Member]
Office And Laboratory Space [Member]
Office Lab And Manufacturing Leases [Member]
Consolidation Items [Axis]
Operating Segments [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Name
Auditor Location
Statement of Financial Position [Abstract]
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Deferred offering costs
Prepaid expenses and other current assets
TOTAL CURRENT ASSETS
Property and equipment, net
Operating lease right-of-use asset, net
Patents, net
Restricted cash
Deposits
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
Due to related parties
Operating lease liability, current portion
Other current liabilities
TOTAL CURRENT LIABILITIES
Operating lease liability, less current portion
TOTAL LIABILITIES
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 100,000,000 shares authorized at March 31, 2026 and 6,000,000 shares authorized at March 31, 2025; 1,570,449 issued and outstanding at March 31, 2026 and 258,531 shares issued and 201,074 outstanding at March 31, 2025
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
OPERATING COSTS AND EXPENSES
Professional fees
Payroll and related expenses
General and administrative
Total operating expenses
OPERATING LOSS
OTHER INCOME (EXPENSE), NET
Interest income
Other income
Interest expense
Other expense
Total other income (expense), net
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
Basic net loss per share attributable to common stockholders
Diluted net loss per share attributable to common stockholders
Weighted average number of common shares outstanding - basic
Weighted average number of common shares outstanding - diluted
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
OTHER COMPREHENSIVE LOSS
COMPREHENSIVE LOSS
Statement [Table]
Statement [Line Items]
Beginning balance
Beginning balance, shares
Issuances of common stock for public offering, net
Issuances of common stock for public offering, net, shares
Issuances of pre-funded warrants and warrants to institutional investors (including exercise of existing warrants), net of offering costs
Issuances of pre-funded warrants and warrants to institutional investors (including exercise of existing warrants), net of offering costs, shares
Exercise of pre-funded warrants
Exercise of pre-funded warrants, shares
Issuance of common stock upon Class A and Class B warrant exercises, net
Issuance of common stock upon Class A and Class B warrant exercises, net, shares
Issuance of common shares upon vesting of restricted stock units and net stock option exercises
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares
Stock-based compensation expense
Rounding for reverse split, shares
Warrant Inducement
Net loss
Other comprehensive loss
Ending balance
Ending balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Non-cash lease expense
Warrant Inducement Expense
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable and other current liabilities
Due to related parties
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Cash used in investing activities
Cash flows from financing activities:
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units
Gross proceeds from the issuance of common stock and pre-funded warrants
Payments for offering costs related to equity issuance
Proceeds from exercise of warrants – standard terms
Proceeds from exercise of warrants – induced terms
Commission paid related to warrant inducement
Legal fees paid related to warrant inducement
Payments for deferred offering costs related to future equity issuance
Net cash provided by financing activities
Effect of Exchange Rate on Changes on Cash
Net (decrease) increase in cash and cash equivalents and restricted cash
Cash and cash equivalents restricted cash at beginning of year
Cash and restricted cash
Supplemental information of non-cash investing and financing activities:
Issuance of shares under vested restricted stock units, net stock option exercises and unvested share issuance for services
Disposal of fully depreciated property
Warrant modification costs
Deferred offering costs not yet paid
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents
Restricted cash
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Award Timing Disclosures [Line Items]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Accounting Policies [Abstract]
ORGANIZATION, LIQUIDITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Property, Plant, and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET
Intangible Asset, Goodwill and Other [Abstract]
PATENTS, NET
Equity [Abstract]
EQUITY TRANSACTIONS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Other Liabilities Disclosure [Abstract]
OTHER CURRENT LIABILITIES
Income Tax Disclosure [Abstract]
INCOME TAXES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Segment Reporting [Abstract]
SEGMENT REPORTING
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
ORGANIZATION
LIQUIDITY AND GOING CONCERN
PRINCIPLES OF CONSOLIDATION
RISKS AND UNCERTAINTIES
USE OF ESTIMATES
CASH AND CASH EQUIVALENTS
CONCENTRATIONS OF CREDIT RISKS
RESTRICTED CASH
PROPERTY AND EQUIPMENT
INCOME TAXES
LONG-LIVED ASSETS
LOSS PER SHARE
REVENUE RECOGNITION
STOCK-BASED COMPENSATION
PATENTS
STOCK PURCHASE WARRANTS
RESEARCH AND DEVELOPMENT EXPENSES
OFF-BALANCE SHEET ARRANGEMENTS
SIGNIFICANT RECENT ACCOUNTING PRONOUNCEMENTS
Schedule of cash and cash equivalents
Schedule of share-based compensation expenses
Schedule of property and equipment, net
Schedule of patents, net
Schedule of warrant activity
Schedule of warrant activity exercisable and outstanding
Schedule of options outstanding that have vested and are expected to vest
Schedule of stock option activity
Schedule of nonvested shares
Schedule of detail of options outstanding and exercisable by exercise price
Schedule of RSUs
Schedule of stock-based compensation
Schedule of amounts due to related parties
Schedule of other current liabilities
Schedule of loss before income taxes
Schedule of deferred tax assets
Schedule of provision for income taxes
Schedule of lease maturity
Schedule of significant expense categories
Cash and Cash Equivalent [Table]
Cash and Cash Equivalents [Line Items]
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Table]
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]
Vesting of Stock Options and Restricted Stock Units
Total Stock-Based Compensation Expense
Basic loss per common share
Diluted loss per common share
Accumulated deficit
Cash balances over insured amount
Cash equivalents of US treasury bills
Restricted cash
Converted to money market deposit account
Uncertain tax positions
Asset impairment charges
Antidilutive shares
Research and development expenses
Australian research and development expense
Number of Reportable Segments
Furniture and office equipment, at cost
Add: additions
Less: disposals
Leasehold improvements
Gross property and equipment
Less: accumulated depreciation
Fixed assets, net
Depreciation expense
Initial cost of fully depreciated furniture and equipment disposal
Issued patents
Accumulated amortization
Patents, net
Amortization of patents
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning balance
Weighted average exercise price, outstanding
Warrants granted
Weighted average exercise price, granted
Warrants exercised
Weighted average exercise price, exercised
Warrants cancelled/forfeited
Weighted average exercise price, cancelled/forfeited
Warrants outstanding, ending balance
Weighted average exercise price, outstanding
Warrants exercisable
Weighted average exercise price, exercisable
Warrants Outstanding
Weighted Average Remaining Life (Years)
Weighted Average Exercise Price, Outstanding
Number of options, vested
Weighted average exercise price options vested
Weighted average remaining contractual term options vested
Number of options, expected to vest
Weighted average exercise price options expected to vest
Total options outstanding
Stock options outstanding, beginning balance
Weighted average exercise price, beginning price
Stock options granted
Stock options cancelled/forfeited
Weighted average exercise price, cancelled/forfeited
Stock options outstanding, ending balance
Weighted average exercise price, ending price
Stock options exercisable
Weighted average exercise price, exercisable
Nonvested shares outstanding, beginning balance
Weighted average grant date fair value nonvested shares outstanding, beginning balance
Options vested
Weighted average grant date fair value nonvested shares outstanding, vested
Options forfeited
Weighted average grant date fair value nonvested shares outstanding, forfeited
Nonvested shares outstanding, ending balance
Stock options outstanding
Weighted average remaining life (years)
Weighted average exercise price, outstanding
RSUs nonvested
RSU's granted
RSU's vested
Stock based compensation
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Reverse stock split
Warrants purchase
Warrants per share exercise price
Exercise price reduced
Warrants issued
Gross proceeds offering costs
Warrants exercised
Common stock for additional proceeds
Sale of stock
Sale of stock per value
Gross proceeds from offering, before deducting placement fees and other offering expenses
Net proceeds, of offering deducting placement fees and expenses and other offering expenses payable
Cash fee percentage
Payment of offering costs
Number of shares granted
Terms of awards
Warrant, description
Gross proceeds from exercise
Shares issued
Legal fees expenses
Warrants expiry date
Proceeds from sale of equity
Issued warrants shares
Issued of warrant inducement shares
Issued of warrant inducement shares exercised
Shares available for grant
Stock option grants
Weighted average grant date fair value of RSUs granted
Stock option exercises
Intrinsic value per share
Unrecognized compensation cost related to share-based payments
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Total due to related parties
Accrued unpaid fees
Accrued salary and related expenses
D&O insurance premium financing (See Note 8)
Accrued professional fees
Accrued G&A
Accrued resale registration
Total other current liabilities
Domestic
Foreign
Worldwide loss
Deferred tax assets:
Net operating loss carryforwards
Capitalized research and development costs
Research and development tax credits
Stock compensation
Gross deferred tax assets
Total deferred tax liabilities
Net deferred tax assets
Valuation allowance for deferred tax assets
Net deferred tax assets
Rate Federal statutory income tax benefit
Rate Federal statutory income tax benefit, percentage
State taxes, net of federal benefit
State taxes, net of federal benefit, percentage
Federal return-to-provision adjustments
Federal return-to-provision adjustments, percentage
State return-to-provision adjustments
State return-to-provision adjustments, percentage
Expiration of net operating loss carryforwards
Expiration of net operating loss carryforwards, percentage
Non-deductible items
Non-deductible items, percentage
Change in valuation allowance
Change in valuation allowance, percentage
Effective income tax rate
Effective income tax rate, percentage
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Net operating loss carryforward
Unrecognized tax benefits
2027
Total minimum lease payments
Less amount representing imputed interest
Present value of minimum lease payments
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Lease description
Lease frequency of periodic payment
Lease periodic payment
Remaining lease term
Lease weighted average discount rate
Operating lease right-of-use asset
Operating lease expense
Contractual Obligation
Payments of Financing Costs
Other Commitment
Debt Instrument, Interest Rate, Stated Percentage
Debt Instrument, Payment Terms
Segment Reporting [Table]
Segment Reporting [Line Items]
Research and development
Cash used in operating activities
Number of Operating Segments
Manufacturing Space [Member]
Office And Laboratory Space [Member]
Office Lab And Manufacturing Leases [Member]
Non Employee Directors [Member]
Separation Agreement [Member]
Accrued Board Fees [Member]
Accrued Vacation To All Employees [Member]
Accrued Separation Expenses [Member]
Cash In US Bank [Member]
Cash Equivalents In US Treasury Bills [Member]
Cash In Australian Bank [Member]
JP Morgan Chase [Member]
Stock Based Compensation [Member]
Prefunded Warrants [Member]
Common Warrants [Member]
Inducement Warrants [Member]
Placement Agent Warrants [Member]
May 2024 Public Offering [Member]
Class A Warrants [Member]
Securities Purchase Agreement [Member]
Director 4 [Member]
Class B Warrants [Member]
Placement Agent [Member]
Range Of Exercise Price 2 [Member]
Range Of Exercise Price 1 [Member]
Exercise Price 1 [Member]
Exercise Price 2 [Member]
Director 1 [Member]
Director 2 [Member]
Director 3 [Member]
December 2025 Warrant Inducment [Member]
September 2025 Public Offering [Member]
Accrued Vacation Balances [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Interest Expense, Nonoperating
Other Nonoperating Expense
Nonoperating Income (Expense)
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable, Related Parties
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payment, Tax Withholding, Share-Based Payment Arrangement
CommissionPaidRelatedToWarrantInducement
PaymentsForLegalFeesPaidForWarrantInducement
PaymentsOfDeferredStockOfferingCosts
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Restricted Cash
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Income Tax, Policy [Policy Text Block]
Property, Plant, and Equipment, before Accumulated Depreciation, Disposition
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Intangible Asset, Finite-Lived, Accumulated Amortization
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, Percent
Lessee, Operating Lease, Liability, Undiscounted Excess Amount